系统性炎症指数,疾病严重程度和COVID-19患者的死亡率:系统性审查和元分析
Arduino A Mangoni1,2, Angelo Zinellu3
1Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
系统性炎症指数 (SII) 是预测严重COVID-19结果的有价值生物标志物. 入院时较高的SII水平与COVID-19患者严重疾病和死亡率的风险增加有关.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 生物标志物 生物标志物
背景情况:
- 系统性炎症与严重的COVID-19和死亡率有关.
- 针对COVID-19风险分层的特定炎症生物标志物的实用性仍然不确定.
结论:
- 系统性炎症指数 (SII) 是一个可靠的炎症生物标志物,来自常规的血液学参数.
- 入院时的SII与严重的COVID-19和死亡率有显著的关联.
- SII可以帮助COVID-19患者早期风险分层.
更多相关视频
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Inflammatory Response I: Vascular and Cellular
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Myocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
